Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

GLP-1 drugs may lower the risk of some obesity-related cancers, according to an observational study of people who were overweight or had obesity.

Jameela Jamil is clarifying her previous statement regarding Serena Williams and GLP-1s. Here's what she said.

Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it ...

About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...

Celebrities have access to doctors that most others don’t,” says Jameela Jamil, who flagged the risks of GLP-1s like those ...

In a recent video spot, the 43-year-old athlete reveals that Ro helped her lose 31 pounds in eight months. “Yes, I’m on Ro.

The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.

GreensKeeper Asset Management, an investment management company, released its second-quarter 2025 investor letter. A copy of ...

Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a ...

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...